CLARENTIS® Technologies
The Global Standard in Hypochlorous Acid Technology
Clarentis® Technologies, LLC, is an asset-light intellectual property and licensing company that owns the most rigorously validated, eco-friendly electrochemical activation (ECA) technology platform in the United States. Five patents have been issued in the United States and one each in Japan and Singapore to protect its proprietary manufacturing process.
The EPA has registered Ultra-Lyte® produced with Clarentis equipment as medical hospital disinfectant. EPA Reg. No. 86854-1 allows Clarentis to make claims against Clostridium difficile and Candida auris.
The FDA has approved Clarentis’ food contact substances FCN 2188 and FCN 2316 with hypochlorous acid (HOCl) as active ingredient.
FCN 2188 allows the onsite manufacturing and use of Ultra-Lyte® as an antimicrobial agent at a concentration up to 60 ppm of free available chlorine (FAC) in the production and preparation of whole or cut meat, poultry; processed, comminuted, and preformed meat and poultry; fish and seafood; fruits, vegetables; and shell eggs.
FCN 2316 allows Ultra-Lyte® or Ultra- Lyte® Fresh, to be used as an antimicrobial agent in an aqueous solution in the preparation of fruits and vegetables (" Produce Wash"), fish and seafood, and shell eggs, between 25-60 ppm free available (FAC) with a shelf life of 6 months. The Benefit: This entirely removes a secondary washing step, preserving thousands of gallons of clean water daily, saving massive amounts of time, and ensuring zero accidental chemical carryover that could compromise the cleaning process.
Four studies published in the Journal of Hospital Infection validate Clarentis Technologies' electrochemical activation (ECA) system, demonstrating its ability to safely disinfect water infrastructure, eradicate biofilms, and provide automated, large-scale infection control. The research confirms the system's effectiveness in preventing the trafficking of antimicrobial-resistant pathogens within hospital wastewater systems, offering a complete framework for reducing HAI risks (see research).
